[Pharmaco-economics of hypolipidemic agents: analysis of factors influencing the cost-effectiveness relation].

Abstract

The demonstration that stains reduce the risk of cardiovascular diseases, in both secondary and primary prevention trials, led to the recent publication of sophisticated pharmaco-economical studies. A lot of factors may influence the cost-effectiveness ratio of the pharmacological intervention, especially the mode of calculation of various costs, the… (More)

Topics

  • Presentations referencing similar topics